Literature DB >> 17699355

Use of hospice in the United States dialysis population.

Anne M Murray1, Cheryl Arko, Shu-Cheng Chen, David T Gilbertson, Alvin H Moss.   

Abstract

Hospice is recognized for providing excellent end-of-life care but may be underused by dialysis patients. Hospice use and related outcomes were measured among dialysis patients, and factors that were associated with hospice use were identified. The 2-yr US Renal Data System dialysis patients who died between January 1, 2001, and December 31, 2002, and hospice claims from the Centers for Medicare &amp; Medicaid Services were examined to measure prevalence, factors, and costs that were associated with dialysis withdrawal and hospice use. Of the 115,239 deceased patients, 21.8% withdrew from dialysis and 13.5% used hospice. Of those who withdrew, 41.9% used hospice. Failure to thrive was the most common reason for dialysis withdrawal (42.9%). On multivariable logistic regression analysis, factors that were significantly associated with hospice referral among patients who withdrew from dialysis were age, race, reason for withdrawal, ability to walk or transfer at dialysis initiation, and state of residence. Among patients who withdrew from dialysis and used hospice, median cost of per-patient care during the last week of life was $1858, compared with $4878 for nonhospice patients (P < 0.001); hospitalization costs accounted for most of that difference. Only 22.9% of dialysis hospice patients died in the hospital, compared with 69.0% of nonhospice patients (P < 0.001). A minority of dialysis patients use hospice, even among patients who withdrew from dialysis, whose death usually is certain. Increased hospice use may enable more dialysis patients to die at home, with substantial cost savings. Research regarding additional benefits of hospice care for dialysis patients is needed.

Entities:  

Mesh:

Year:  2006        PMID: 17699355     DOI: 10.2215/CJN.00970306

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  53 in total

Review 1.  Renal replacement therapy in the elderly population.

Authors:  Joseph R Berger; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

2.  Are there alternatives to hemodialysis for the elderly patient with end-stage renal failure?

Authors:  Bjorg Thorsteinsdottir; Keith M Swetz; Molly A Feely; Paul S Mueller; Amy W Williams
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

3.  Increasing hospice services for elderly patients maintained with hemodialysis.

Authors:  Lewis M Cohen; Robin Ruthazer; Michael J Germain
Journal:  J Palliat Med       Date:  2010-07       Impact factor: 2.947

Review 4.  Should there be an expanded role for palliative care in end-stage renal disease?

Authors:  Manjula Kurella Tamura; Lewis M Cohen
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-11       Impact factor: 2.894

5.  The Ethics of Chronic Dialysis for the Older Patient: Time to Reevaluate the Norms.

Authors:  Bjorg Thorsteinsdottir; Keith M Swetz; Robert C Albright
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-14       Impact factor: 8.237

6.  What determines whether a patient initiates chronic renal replacement therapy?

Authors:  Michael J Germain; Lewis M Cohen
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

7.  Conservative Management and End-of-Life Care in an Australian Cohort with ESRD.

Authors:  Rachael L Morton; Angela C Webster; Kevin McGeechan; Kirsten Howard; Fliss E M Murtagh; Nicholas A Gray; Peter G Kerr; Michael J Germain; Paul Snelling
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-03       Impact factor: 8.237

8.  Trends in Receipt of Intensive Procedures at the End of Life Among Patients Treated With Maintenance Dialysis.

Authors:  Nwamaka D Eneanya; Susan M Hailpern; Ann M O'Hare; Manjula Kurella Tamura; Ronit Katz; William Kreuter; Maria E Montez-Rath; Paul L Hebert; Yoshio N Hall
Journal:  Am J Kidney Dis       Date:  2016-09-29       Impact factor: 8.860

9.  Geographic variation in black-white differences in end-of-life care for patients with ESRD.

Authors:  Bernadette A Thomas; Rudolph A Rodriguez; Edward J Boyko; Cassianne Robinson-Cohen; Annette L Fitzpatrick; Ann M O'Hare
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 8.237

10.  End-of-life care preferences and needs: perceptions of patients with chronic kidney disease.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.